Table II.
Infant | n | OxyHb | DeoxyHb | TotalHb | ||||||
---|---|---|---|---|---|---|---|---|---|---|
t min (sec) | Mean (SD), mM · cm | P | t max (sec) | Mean (SD), mM · cm | P | t min (sec) | Mean (SD), mM · cm | P | ||
M.Y. | 10 | 17.2 | −0. 0217 (0. 0055) | 0.005 | 20.4 | 0. 0011 (0. 0052) | 0.005 | 13.1 | −0. 0152 (0. 0046) | 0.005 |
M.K. | 10 | 13.1 | −0. 0135 (0. 0048) | 0.005 | 14.1 | 0. 0122 (0. 0038) | 0.005 | 8.9 | −0. 0049 (0. 0020) | 0.005 |
I.K. | 10 | 16.2 | −0. 0101 (0. 0062) | 0.009 | 17.2 | 0. 0067 (0. 0049) | 0.200 | 13.1 | −0. 0053 (0. 0030) | 0.047 |
K.M. | 9 | 10.0 | −0. 0081 (0. 0055) | 0.038 | 12.0 | 0. 0078 (0. 0045) | 0. 0210 | 7.9 | −0. 0026 (0. 0022) | 0.051 |
U.A. | 10 | 21.4 | −0. 0119 (0. 0134) | 0.005 | 25.1 | 0. 0099 (0. 0067) | 0. 0170 | 18.3 | −0. 0069 (0. 0110) | 0.005 |
Number of trials (n), time to bottom or peak (t min or t max), mean changes in [oxyHb], [deoxyHb], and [totalHb] (in mM · cm), and level of significance (Wilcoxon's signed‐rank test) for each subject.